Shortly before the outbreak of the pandemic, Attana initiated an activity aimed at establishing three reputable reference customers in the United States. Since then, the selected customers have carried out leading experiments with e.g. T cells for palliative care and tissue from biopsies. One of these customers collaborates with a research institute, which has now placed a first small order to perform kinetic interaction analysis of tissue.

The new customer gets access to an existing Attana instrument and begins training users already this month. After that, the customer continues their planned research work during the first half of 2024, which means that they buy chips and advice from Attana. The goal is for the new customer to start the purchasing process for their own instrument within 12 months.